Home › Funds › BlackBarn Capital Partners LP › VKTX
BlackBarn Capital Partners LP position in VKTX
VIKING THERAPEUTICS INC · Health Care
BlackBarn Capital Partners LP reported holding 250,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.8M, representing 0.90% of its reported portfolio and ranking #18 among its reported holdings. BlackBarn Capital Partners LP has disclosed VKTX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BlackBarn Capital Partners LP's VKTX position evolved
BlackBarn Capital Partners LP first disclosed a stake in VKTX in Q2 2025 at 350,000 shares (US$9.3M). The position peaked in Q1 2026 at 621,450 shares, worth US$20.2M. Across 5 filings, BlackBarn Capital Partners LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$9.8M — a reduction of -371,450 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2025 (shares rose 34% over the following quarter), a 60% trim in Q2 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 350.00K | $9.28M | New |
| Q3 2025 | 500.00K | $13.14M | Add |
| Q4 2025 | 550.00K | $19.35M | Add |
| Q1 2026 | 621.45K | $20.22M | Add |
| Q2 2026 | 250.00K | $9.75M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on BlackBarn Capital Partners LP
FAQ
How long has BlackBarn Capital Partners LP held VKTX?
BlackBarn Capital Partners LP has disclosed VKTX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is BlackBarn Capital Partners LP's current position in VKTX?
As of Q2 2026, BlackBarn Capital Partners LP holds 250.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $9.75M, representing 0.90% of its reported portfolio and ranking #18.
Has BlackBarn Capital Partners LP been buying or selling VKTX?
In the latest 13F filing (Q2 2026), BlackBarn Capital Partners LP reduced its position in VKTX. The position peaked in Q1 2026 at 621.45K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.